Business Wire

Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings Inc. (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced that the Japan Patent Office ...
Business Wire

Cardio Diagnostics Holdings, Inc Receives Innovative Technology Contract from Vizient for Its Novel AI-Driven Precision Heart Disease Tests – Epi+Gen CHD & PrecisionCHD

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced its AI-driven molecular ...
Healio

AI technology to assess cardiovascular risk through retinal images receives CE, UKCA marks

Please provide your email address to receive an email when new articles are posted on . The European and UK markets will have access to the CLAiR technology from Toku. CLAiR assesses cardiovascular ...
The Business Journals

Pulse check: 3 ways health providers can leverage data, advanced technology to improve cardiovascular care

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. One person dies of cardiovascular disease (CVD) every 34 ...
Forbes

How Technology Will Drive Value-Based Models For Cardiovascular Care

Modern cardiovascular care involves human acumen, complex data and collaborative intelligence between the two. Payment models are based on well-defined tests and procedures and are baffled by the ...
Medical Xpress

Wearable tech takes on heart health: Exploring advancements in cardiovascular disease monitoring

Cardiovascular diseases remain a global health crisis, spurring an urgent demand for innovative diagnostic tools that enable early detection and effective treatment. Wearable heart sound devices ...
Nasdaq

CardioDialysisTM, a Next-Generation Technology to Reduce Major Adverse Cardiovascular Events

SAN DIEGO, CA - March 27, 2026 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), developer of CardioDialysisTM, a medical device that enables continuous ...